CClinicalTrials.gg
CompletedNCT05089032PEOpLeC19-ENUpdated Mar 14, 2025

The Practice of Providing Palliative Care in the Situation of the COVID-19 Pandemic

An observational study in COVID-19 Pandemic and End-of-life, sponsored by Masaryk University. Completed at 1 site in Czechia. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-03-14.

Sponsored by Masaryk University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
215
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The practice of providing palliative care in the situation of the COVID-19 pandemic in the perspective of physicians and nurses - survey study (PEOpLe-C19 study)

Read the detailed description

Pandemic of coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2) causing the disease COVID-19 (Coronavirus Disease 2019) overwhelmed healthcare and brought new challenges and stressful situations. In a short time, intensive care units (ICU) capacities were filled in many countries and regions. Due to the need for an excessive number of patients requiring intensive care, physicians and nurses who do not routinely provide care to critically ill patients or do not have the appropriate training (non-ICU clinician) were involved in the care of COVID-19 patients. In this context, ICU directly dedicated to caring for patients with COVID-19 ARDS (Acute Respiratory Distress Syndrome) was also opened. Non-ICU clinicians were more or less involved together with the standard ICU staff in palliative care, including End-of-Life decision (EOLD) making, even in a situation of limited, scarce resources (equipment or personnel). New workplace and scope of work, which did not correspond to the standard activity or education, most likely led to an increased stress load. EOLD can also be one of the factors leading to increased stress levels. The project aims to describe the practice of palliative care for patients with COVID-19 in a situation of pandemic COVID-19 and to identify factors leading to possible moral distress related to EOLD.

02

Conditions studied

  • COVID-19 Pandemic
  • End-of-life

Browse trials for

Keywords

  • covid-19
  • Palliative Care
  • end-of-life
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 215 is below the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Masaryk University is the lead sponsor of 40 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Healthcare providers (physicians and nurses) providing care to patients with COVID-19 admitted at ICU in period of COVID-19 pandemic.

Inclusion criteria

  • Healthcare providers (physicians/nurses)
  • Involvement in care for patients with COVID-19 admitted at intensive care unit

Exclusion criteria

Exclusion Criteria:

  • Non-ICU staff
  • not involved in care for patients with COVID-19
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
215 participants (actual)
Patient registry
No

Groups and cohorts

  • Physicians
  • Nurses
06

What researchers measure

Primary outcomes

  1. Change of practice of providing palliative care at ICU in COVID-19 pandemic

    Change of practice of providing palliative care including EOLD practice in patients with COVID-19 admitted at ICU during pandemic.

    Time frame: Through study completion, an average of 1 month

Secondary outcomes

  1. Identify factors leading to moral distress during the COVID-19 pandemic

    Identify factors leading to moral distress during COVID-19 pandemic and describe possible different risk factors by profession

    Time frame: Through study completion, an average of 1 month

07

Study locations

1 site
  • Masaryk University
    Brno, 62500, Czechia
08

References and documents

Study documents

  • Study protocol · Jun 15, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05089032
Lead sponsor
Masaryk University
Collaborators
European Society of Intensive Care Medicine, European Society of Anaesthesiology and Intensive Care, Brno University Hospital
Responsible party
Jan Malaska (Head of research group, Masaryk University) — Principal investigator
First posted
Oct 22, 2021
Start date
May 1, 2023
Primary completion
Feb 29, 2024
Completion
Feb 29, 2024
Last update
Mar 14, 2025

Study contacts

Tereza Prokopova, MD
principal investigator · University Hospital Brno

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion